title: Proposed EU-India free trade agreement could impede manufacture of generic HIV drugs.
abstract: Medical experts are warning that an international trade agreement being brokered between the European Union (EU) and India could greatly restrict the access of people living with HIV in the developing world to life-saving antiretroviral medication.
authors.affiliation: Canadian HIV/AIDS Legal Network. schu@aidslaw.ca
authors.forename: Sandra Ka Hon
authors.initials: SK
authors.lastname: Chu
mesh_terms: D019380:Anti-HIV Agents / Q000138:chemical synthesis*; D003132:Commerce / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D005062:European Union; D006801:Humans; D007194:India
chemical_list: D019380:Anti-HIV Agents; D016568:Drugs, Generic